Clinical Trials · NCT01382589
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 15
- Start date
- Sep 2011
- Locations
- See registry
- Primary endpoint
- To compare the efficacy of afamelanotide implants and NB-UVB light in the treatment of nonsegmental vitiligo